An enzyme-linked immunosorbent assay for therapeutic drug monitoring of cetuximab, Ther Drug Monit, vol.31, pp.597-601, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00375861
A phase 1 escalating single-dose and weekly fixed-dose study of cetuximab: pharmacokinetic and pharmacodynamic rationale for dosing, Clin Cancer Res, vol.13, pp.986-993, 2007. ,